Phase 1a of the trial examined dose escalation of IO-202 as a monotherapy and in combination with azacitidine. Phase 1b of ...

CR or mCR in 86% of patients within the first 12 months - Venetoclax-resistant secondary AML transformed from CMML responds to lenzilumab BURLINGAME, CA / ACCESS Newswire / November 4, 2025 / Taran ...

The regimen of bexmarilimab and azacitidine (Vidaza) demonstrated a highly promising efficacy profile with a manageable ...

HOUSTON, Nov. 11, 2025 /PRNewswire/ — Salarius Pharmaceuticals, Inc. (“Salarius” or the “Company”) (NASDAQ: SLRX) today announced the pricing of an underwritten public offering for gross proceeds of ...

Identy.io, a leader in biometric identification, today announced it achieved NIST ISO 30107-3 Level 2 Presentation Attack Detection (PAD) Certification with a perfect score for its Face SDK v6.3.0 ...

Optiv, the cyber advisory and solutions leader, is proud to share CEO Kevin Lynch was named Best Solution Provider CEO of the Year by CRN®, a brand of The Channel Company, at the inaugural Best of the ...

Aptose Biosciences Inc. (($APTOF)) announced an update on their ongoing clinical study. Aptose Biosciences Inc. is conducting a clinical study ...

Developed by Ascentage Pharma, lisaftoclax is an orally available Bcl-2 inhibitor. Early data from the studies have demonstrated effects on hematologic malignancies and solid tumors. Lisaftoclax is ...

The Boston-based biotech is axing Phase II plans for its only clinical-stage asset, in a bid to maximise shareholder value.

Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...

What are the best Cities Skylines 2 mods? With bigger maps, signature buildings, and even new weather cycles, you'd be forgiven for thinking that Cities Skylines 2 has everything you could possibly ...